| abstract |
immunoglobulin, antibody, pharmaceutical composition use of the antibody and these are antibodies that specifically bind to her2 / neu, and particularly chimeric 4ds antibodies against her2 / neu, which have reduced glycosylation when compared to known 4ds antibodies. the invention also relates to methods of using the 4ds antibodies and compositions that comprise the same in the prognosis and therapy of diseases such as cancer, diagnosis, autoimmune diseases, inflammatory disorders, and infectious disease. |